Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Trintellix (vortioxetine)
pCPA File Number:
21165
Negotiation Status:
Concluded with an LOI
Indication(s):
Major Depressive Disorder
Sponsor/Manufacturer:
Lundbeck Canada Inc.
CADTH Project Number:
SR0611-000
pCPA Engagement Letter Issued:
2020-07-06
Negotiation Process Concluded:
2020-12-03